Menu Search
Equities

Gimv NV

GI3:DUS

Gimv NV

Actions
  • Price (EUR)37.60
  • Today's Change0.25 / 0.67%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 06 2024 07:12 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Gimv NV is a Belgium-based investment company. The five segments of the Company are investment platforms: Consumer, Healthcare, Life sciences, Smart industries, Sustainable cities. The Consumer platform focuses on companies that respond to current and future consumer needs and preferences. In the Health and Care platform, the Company invests in biotechnology, medical technology, and service companies in the health & care sector. Through Smart Industries platform the Company invests in innovation and intelligent technologies. The Sustainable Cities platform focuses on construction & materials, energy and environment, transport, logistics and mobility, and industrial services. The Company invests as well, in third-party funds and infrastructure.

  • Revenue in EUR (TTM)390.66m
  • Net income in EUR217.13m
  • Incorporated1980
  • Employees93.00
  • Location
    Gimv NVKarel Oomsstraat 37ANTWERPEN 2018BelgiumBEL
  • Phone+32 32902100
  • Fax+32 32902105
  • Websitehttps://www.gimv.com/en
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		GIMB:BRU since
announced		Transaction
value
SMG Sportplatzmaschinenbau GmbHDeal completed07 Jun 202407 Jun 2024Deal completed-17.70%--
Data delayed at least 15 minutes, as of Nov 06 2024 09:19 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.